Evidence map›Paper›PMID 37193300›Full record

ArticleInfection and drug resistance2023

Multiplex Polymerase Chain Reaction/Pooled Antibiotic Susceptibility Testing Was Not Associated with Increased Antibiotic Resistance in Management of Complicated Urinary Tract Infections.

Howard J Korman, Mohit Mathur, Natalie Luke, Dakun Wang, Xihua Zhao, Michael Levin, David L Wenzler, David Baunoch

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Howard J KormanComprehensive Urology Division, Michigan Healthcare Professionals, Royal Oak, MI, USA.
Mohit MathurDepartment of Medical Affairs, Pathnostics, Irvine, CA, USA.
Natalie LukeDepartment of Medical Affairs, Pathnostics, Irvine, CA, USA.ORCID 0000-0003-0732-3622
Dakun WangDepartment of Writing, Stat4Ward, Pittsburgh, PA, USA.
Xihua ZhaoDepartment of Statistical Analysis, Stat4Ward, Pittsburgh, PA, USA.
Michael LevinComprehensive Urology Division, Michigan Healthcare Professionals, Royal Oak, MI, USA.
David L WenzlerComprehensive Urology Division, Michigan Healthcare Professionals, Royal Oak, MI, USA.
David BaunochDepartment of Research and Development, Pathnostics, Irvine, CA, USA.
Comprehensive Urology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To compare antibiotic resistance results at different time points in patients with urinary tract infections (UTIs), who were either treated based upon a combined multiplex polymerase chain reaction (M-PCR) and pooled antibiotic susceptibility test (P-AST) or were not treated. Methods: The M-PCR/P-AST test utilized here detects 30 UTI pathogens or group of pathogens, 32 antibiotic resistance (ABR) genes, and phenotypic susceptibility to 19 antibiotics. We compared the presence or absence of ABR genes and the number of resistant antibiotics, at baseline (Day 0) and 5-28 days (Day 5-28) after clinical management in the antibiotic-treated (n = 52) and untreated groups (n = 12). Results: Our results demonstrated that higher percentage of patients had a reduction in ABR gene detection in the treated compared to the untreated group (38.5% reduction vs 0%, Conclusion: Our results with both resistance gene and phenotypic antibiotic susceptibility results demonstrated that treatment based upon rapid and sensitive M-PCR/P-AST resulted in reduction rather than induction of antibiotic resistance in symptomatic patients with suspected complicated UTI (cUTI) in an urology setting, indicating this type of test is valuable in the management of these types of patients. Further studies of the causes of gene reduction, including elimination of ABR gene-carrying bacteria and loss of ABR gene(s), are warranted.

Indexed as

antibiotic resistanceantibiotic resistance genescomplicated urinary tract infectiondiagnostic testingpolymerase chain reactionurinary tract infection

Identifiers

PMID37193300
PMCPMC10182799
OpenAlexW4376871137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.